We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.

Delisted

TARO was delisted on the 21st of June, 2024.

127 hedge funds and large institutions have $521M invested in Taro Pharmaceutical Industries Ltd. in 2017 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 27 increasing their positions, 44 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

5% less funds holding

Funds holding: 133127 (-6)

13% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 39

18% less capital invested

Capital invested by funds: $633M → $521M (-$112M)

39% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 44

87% less call options, than puts

Call options by funds: $280K | Put options by funds: $2.15M

Holders
127
Holders Change
-6
Holders Change %
-4.51%
% of All Funds
2.88%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
34
Increased
27
Reduced
44
Closed
39
Calls
$280K
Puts
$2.15M
Net Calls
-$1.87M
Net Calls Change
+$531K
Name Holding Trade Value Shares
Change
Change in
Stake
Korea Investment Corp
126
Korea Investment Corp
South Korea
-$5.18M -46,000 Closed
Asset Management One
127
Asset Management One
Japan
-$4.74M -42,086 Closed
JAM
128
Jupiter Asset Management
United Kingdom
-$4.58M -40,673 Closed
Mitsubishi UFJ Trust & Banking
129
Mitsubishi UFJ Trust & Banking
Japan
-$3.18M -28,206 Closed
AAF
130
Andra AP-fonden
Sweden
-$3.04M -27,000 Closed
TCIM
131
TIAA CREF Investment Management
New York
-$2.59M -23,581 -100%
VRS
132
Virginia Retirement Systems
Virginia
-$2.42M -21,500 Closed
UBS AM
133
UBS AM
Illinois
-$2.18M -19,330 Closed
Los Angeles Capital Management
134
Los Angeles Capital Management
California
-$2.13M -18,877 Closed
Caisse de Depot et Placement du Quebec (CDPQ)
135
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
-$1.96M -17,300 Closed
TA
136
Teachers Advisors
New York
-$1.3M -11,572 Closed
PI
137
Putnam Investments
Massachusetts
-$1.04M -9,236 Closed
State of Wisconsin Investment Board
138
State of Wisconsin Investment Board
Wisconsin
-$1.01M -9,000 Closed
Nisa Investment Advisors
139
Nisa Investment Advisors
Missouri
-$992K -8,800 Closed
California State Teachers Retirement System (CalSTRS)
140
California State Teachers Retirement System (CalSTRS)
California
-$923K -8,192 Closed
AllianceBernstein
141
AllianceBernstein
Tennessee
-$739K -6,558 Closed
XK
142
Xact Kapitalforvaltning
Sweden
-$676K -6,000 Closed
Teacher Retirement System of Texas
143
Teacher Retirement System of Texas
Texas
-$655K -5,814 Closed
Manulife (Manufacturers Life Insurance)
144
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$620K -5,502 Closed
Nomura Asset Management
145
Nomura Asset Management
Japan
-$584K -5,180 Closed
Public Sector Pension Investment Board (PSP Investments)
146
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
-$581K -5,153 Closed
Zurich Cantonal Bank
147
Zurich Cantonal Bank
Switzerland
-$442K -3,922 Closed
BCIM
148
British Columbia Investment Management
British Columbia, Canada
-$383K -3,400 Closed
TD Asset Management
149
TD Asset Management
Ontario, Canada
-$372K -3,300 Closed
NFA
150
Nationwide Fund Advisors
Ohio
-$324K -2,878 Closed

TARO Hedge Fund Activity: Q4 2017 in Review

127 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q4 2017, worth a combined $521M — down 18% from $633M a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of TARO and 34 opened new positions — a net loss of 5 holders — while 44 trimmed existing stakes and 27 added.

The largest buyer was Invesco, adding an estimated $16.9M. The largest seller was BlackRock, cutting an estimated $53.6M.

  • 127 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q4 2017, down from 133 in Q3 2017.
  • Funds reported $521M of Taro Pharmaceutical Industries Ltd. stock for Q4 2017, down 18% quarter-over-quarter.
  • 34 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q4 2017 and 39 closed out, a net change of -5 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q4 2017 was Invesco, an estimated $16.9M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q4 2017 was BlackRock, an estimated $53.6M sold.

Based on aggregated 13F filings for Q4 2017.